About: BioMotiv

An Entity of Type: agent, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

BioMotiv is an accelerator company associated with The Harrington Project, a $340 million initiative centered at University Hospitals of Cleveland. Therapeutic opportunities are identified through relationships with The Harrington Discovery Institute, university and research institutions, disease foundations, and industry sources. Once opportunities are identified, BioMotiv oversees the development, funding, active management, and partnering of the therapeutic products.

thumbnail
Property Value
dbo:abstract
  • BioMotiv is an accelerator company associated with The Harrington Project, a $340 million initiative centered at University Hospitals of Cleveland. Therapeutic opportunities are identified through relationships with The Harrington Discovery Institute, university and research institutions, disease foundations, and industry sources. Once opportunities are identified, BioMotiv oversees the development, funding, active management, and partnering of the therapeutic products. (en)
dbo:foundingYear
  • 2012-01-01 (xsd:gYear)
dbo:industry
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 42576177 (xsd:integer)
dbo:wikiPageLength
  • 8466 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1066058182 (xsd:integer)
dbo:wikiPageWikiLink
dbp:foundation
  • Cleveland, Ohio, 2012 (en)
dbp:industry
  • Biotechnology (en)
dbp:keyPeople
  • Baiju Shah, CEO (en)
dbp:logo
  • BioMotiv_Logo_REvised.jpg (en)
dbp:subsid
  • Allinaire Therapeutics (en)
  • Dual Therapeutics (en)
  • Inclera (en)
  • Kodosil Bio (en)
  • Koutif Therapeutics (en)
  • Nynex Therapeutics (en)
  • Optikira (en)
  • Orca Therapeutics (en)
  • SapVax (en)
  • Sujana (en)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • BioMotiv is an accelerator company associated with The Harrington Project, a $340 million initiative centered at University Hospitals of Cleveland. Therapeutic opportunities are identified through relationships with The Harrington Discovery Institute, university and research institutions, disease foundations, and industry sources. Once opportunities are identified, BioMotiv oversees the development, funding, active management, and partnering of the therapeutic products. (en)
rdfs:label
  • BioMotiv (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License